Skip to main content

Author: Tom Wilemon

Symposium to focus on stem cell transplant, cellular therapies

Feb. 20, 2020—New therapies that re-engineer patients’ T-cells to target cancer and advances in stem cell transplantations that make it easier for patients to be matched with donors are among the topics at an upcoming symposium.

Read more


Advocacy group’s gift boosts lung cancer research efforts

Feb. 13, 2020—An advocacy group for patients with anaplastic lymphoma kinase positive lung cancer has awarded a $500,000 grant dedicated to overcoming treatment resistance to the cancer.

Read more


Stem cell recipient and donor meet in person for first time

Feb. 6, 2020—Josh Ferris was sitting in a hunting blind on Nov. 15, 2018, the first day of deer season in Michigan and the one-year anniversary of his stem cell donation, when he received an email from Todd Adams of Nashville, the recipient of his life-saving gift.

Read more


Vanderbilt-Ingram Cancer Center researchers included in ASCO annual report

Feb. 5, 2020—Two researchers from Vanderbilt-Ingram Cancer Center (VICC) are featured in Clinical Cancer Advances 2020: ASCO’s Annual Report on Progress Against Cancer.

Read more


Vanderbilt-Ingram Cancer Center patient first for new cell engineering platform

Feb. 5, 2020—Rhea Dodd is the first patient treated with an experimental cancer vaccine derived from a completely new cell engineering platform.

Read more


Cancer Center hosting symposium for rural health care providers

Jan. 29, 2020—Vanderbilt-Ingram Cancer Center will host a two-day symposium for health care professionals working with rural populations in February.

Read more


Journey Home Project supports first CAR-T infusion at VA hospital

Jan. 16, 2020—The Tennessee Valley Healthcare System performed its first CAR-T infusion recently at the Veterans Administration hospital in Nashville.

Read more


ACMG issues statement on breast cancer genetic testing

Jan. 16, 2020—According to a statement on behalf of the American College of Medical Genetics and Genomics, there is insufficient evidence to recommend universal genetic testing for BRCA1/2 alone or in combination with multi-gene panels for all breast cancer patients.

Read more


Park named interim Hematology and Oncology director

Jan. 9, 2020—Ben Ho Park, MD, PhD, has been named interim director of the Division of Hematology and Oncology.

Read more


Impact of weight gain from early to middle adulthood explored

Jan. 9, 2020—An analysis of weight gain occurring from early to middle adulthood indicates that the added weight is associated with multiple health outcomes in later life.

Read more


Richmond receives legacy award from Society for Leukocyte Biology

Dec. 12, 2019—Ann Richmond, PhD, Ingram Professor of Cancer Research, is the 2019 recipient of the Society for Leukocyte Biology Legacy Award.

Read more


Balko lands Mary Kay Foundation grant for breast cancer research

Dec. 5, 2019—Vanderbilt-Ingram Cancer Center's Justin Balko, PharmD, PhD, has received a $100,000 research grant from the Mary Kay Foundation.

Read more


Recent Stories from VUMC News and Communications Publications

Betsy Williams has firsthand advice for parents on the fence about whether their adolescent children should be vaccinated for the common human papilloma virus (HPV), which can lead to six types of cancer.  Don’t hesitate. Do it.

Momentum

Betsy Williams has firsthand advice for parents on the fence about whether their adolescent children should be vaccinated for the common human papilloma virus (HPV), which can lead to six types of cancer. Don’t hesitate. Do it.

Keeping pace: Nashville, once a mid-size city with a Southern small-town feel, is experiencing explosive growth.

Vanderbilt Medicine

Keeping pace: Nashville, once a mid-size city with a Southern small-town feel, is experiencing explosive growth.

VUMC campus

VUMC campus

Vanderbilt University School of Medicine entrance

Vanderbilt University School of Medicine entrance

more